Nanopore clinical insights
Technical commentary on sequencing, diagnostics, and clinical metagenomics from the Nanolix team.
Why Nanopore Raw Error Rates Matter More in Clinical Settings Than in Research Labs
Research labs can tolerate a 12-15% raw error rate by running longer runs and averaging across many reads. Clinical point-of-care cannot. We examine why the error problem is fundamentally different at the bedside.
Local Execution vs. Cloud Pipelines: What Changes When Sequencing Moves to the Clinic
Cloud basecalling adds 2-4 hours of latency even with a fast internet connection. In a hospital setting, that latency is often clinically unacceptable. We break down the real-world constraints.
Adaptive Basecalling: How Context-Aware Models Reduce Nanopore Error Rates
Standard basecallers treat each signal window independently. Adaptive models condition on preceding context, dramatically reducing systematic errors in homopolymer regions.
The 45-Minute Diagnostic Window: Why Speed Defines Clinical Utility
Antibiotic stewardship, sepsis management, and infection control decisions are all time-sensitive. We examine how the time-to-result gap maps to actual clinical decision points.
LDT-Compatible Architecture: What Clinical Labs Need to Know Before Deploying Sequencing Software
Sequencing software deployed in a CLIA laboratory for clinical use is a laboratory-developed test. Here is what that means practically.
A Clinical Metagenomics Workflow for Nanopore: From Sample to Pathogen Call
The end-to-end workflow for clinical metagenomics using nanopore sequencing. We walk through each stage and identify the points where software quality has the highest clinical impact.
Hospital-Acquired Infections and the Case for Rapid Whole-Genome Sequencing
HAIs caused by Klebsiella pneumoniae, Acinetobacter baumannii, and Clostridioides difficile are responsible for significant morbidity. Rapid sequencing changes what is possible for outbreak investigation.
Integrating Sequencing Results into the Clinical LIS: HL7 Messaging for Genomic Data
Delivering sequencing results via HL7 v2 ORU messages or FHIR DiagnosticReport resources into the LIS requires careful mapping of genomic findings to standard result vocabularies.
AMR Gene Detection from Nanopore Reads: How Sensitive Can a Local Pipeline Be?
Antimicrobial resistance gene detection from nanopore reads presents specific challenges: read length variation, base-level noise, and distinguishing chromosomal from plasmid-borne resistance.
Respiratory Pathogen Panels vs. Metagenomic Sequencing: When Each Approach Wins
Syndromic panels identify a fixed set of targets fast and cheaply. Metagenomic sequencing identifies anything that is there. The clinical decision depends on pre-test probability and patient population.
A Clinical Microbiologist's Guide to Nanopore Sequencing: What the Technology Actually Does
This guide explains the underlying technology — ionic current signals, pore chemistry, base-call quality scores — in terms relevant to clinical laboratory interpretation.
Sequencing Data Latency at the Bedside: A Practical Breakdown for Hospital IT
Hospital IT teams evaluating sequencing software deployment need to understand where latency enters the workflow. This post walks through a realistic latency budget for cloud vs. local execution architectures.